Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma. Article

authors

  • Zhang, L
  • Morgan, RA
  • Beane, JD
  • Zheng, Z
  • Dudley, ME
  • Kassim, SH
  • Nahvi, AV
  • Ngo, LT
  • Sherry, RM
  • Phan, GQ
  • Hughes, Marybeth S.
  • Kammula, US
  • Feldman, SA
  • Toomey, MA
  • Kerkar, SP
  • Restifo, NP
  • Yang, JC
  • Rosenberg, SA

publication date

  • 2015

published in

PubMed Central ID

  • pmc4433819

start page

  • 2278

end page

  • 88

volume

  • 21

issue

  • 10